TotipotentRX Report issue

For profit Phase 1
Founded: Los Angeles CA United States (2011)
Status: Acquired by Cesca Therapeutics, Inc. (2013)

Organization Overview

First Clinical Trial
2014
NCT03026855
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree